Literature DB >> 15801013

A pilot study to determine whether disability and disease activity are different in African-American and Caucasian patients with rheumatoid arthritis in St. Louis, Missouri, USA.

Ulker Tok Iren1, Mark S Walker, Eric Hochman, Richard Brasington.   

Abstract

OBJECTIVE: To compare the levels of disability and disease activity in African-Americans and Caucasians with rheumatoid arthritis (RA) in an academic medical center practice, and to determine whether the differences are independently associated with ethnicity.
METHODS: Data on socioeconomic, disease related, psychological, and behavioral variables were obtained from 100 outpatients (67 Caucasians, 33 African-Americans) with RA. Functional status was assessed with the Health Assessment Questionnaire (HAQ) and Disease Activity Score (DAS-28). Chi-square and Student t tests were used to test for differences between groups. Multiple regression analysis was used to determine whether ethnicity was associated with these differences independent of other factors known to influence disease outcome.
RESULTS: African-Americans and Caucasians did not differ with respect to age, sex, disease duration, rheumatoid factor positivity, and medication compliance. African-Americans had higher scores than Caucasians for HAQ (1.5 +/- 0.8 vs 0.9 +/- 0.7; p < 0.001) and DAS-28 (5.5 +/- 1.3 vs 4.3 +/- 1.4; p < 0.001). Regression models showed that ethnicity was not independently associated with the higher HAQ and DAS-28 scores when controlled for demographic, socioeconomic, psychological, and behavioral factors. Arthritis self-efficacy approaches significance in the regression model.
CONCLUSION: HAQ disability and RA disease activity were higher in African-Americans than Caucasians in this sample from an academic medical center practice. However, ethnicity was not independently associated with these outcomes when socioeconomic and psychological factors were taken into account. Improvement in self-efficacy has the potential to improve outcome in African-Americans with RA.

Entities:  

Mesh:

Year:  2005        PMID: 15801013

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans.

Authors:  Gabriela Schmajuk; Amal N Trivedi; Daniel H Solomon; Edward Yelin; Laura Trupin; Eliza F Chakravarty; Jinoos Yazdany
Journal:  JAMA       Date:  2011-02-02       Impact factor: 56.272

2.  The effect of the Arthritis Self-Management Program on outcome in African Americans with rheumatoid arthritis served by a public hospital.

Authors:  Doyt L Conn; Yi Pan; Kirk A Easley; Dawn L Comeau; Joyce P Carlone; Steven D Culler; Athan Tiliakos
Journal:  Clin Rheumatol       Date:  2012-09-29       Impact factor: 2.980

3.  Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.

Authors:  Shuling Li; Doyt L Conn; Athan Tiliakos; Gaobin Bao; Kirk A Easley
Journal:  Clin Rheumatol       Date:  2018-01-03       Impact factor: 2.980

4.  Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.

Authors:  Ashutosh Tamhane; David T Redden; Gerald McGwin; Elizabeth E Brown; Andrew O Westfall; Richard J Reynolds; Laura B Hughes; Doyt L Conn; Leigh F Callahan; Beth L Jonas; Edwin A Smith; Richard D Brasington; Larry W Moreland; S Louis Bridges
Journal:  J Rheumatol       Date:  2013-08-15       Impact factor: 4.666

5.  Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African-American rheumatoid arthritis patients.

Authors:  Tanya M Spruill; Gbenga Ogedegbe; Leslie R Harrold; Jeffrey Potter; Jose U Scher; Pamela B Rosenthal; Jeffrey D Greenberg
Journal:  Ann Rheum Dis       Date:  2013-07-31       Impact factor: 19.103

6.  Self-reported osteoarthritis, ethnicity, body mass index, and other associated risk factors in postmenopausal women-results from the Women's Health Initiative.

Authors:  Nicole C Wright; Gail Kershner Riggs; Jeffrey R Lisse; Zhao Chen
Journal:  J Am Geriatr Soc       Date:  2008-07-17       Impact factor: 5.562

7.  The relationship among health literacy, health knowledge, and adherence to treatment in patients with rheumatoid arthritis.

Authors:  Patricia Quinlan; Kwanza O Price; Steven K Magid; Stephen Lyman; Lisa A Mandl; Patricia W Stone
Journal:  HSS J       Date:  2012-12-11

8.  Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.

Authors:  Jeffrey D Greenberg; Tanya M Spruill; Ying Shan; George Reed; Joel M Kremer; Jeffrey Potter; Yusuf Yazici; Gbenga Ogedegbe; Leslie R Harrold
Journal:  Am J Med       Date:  2013-12       Impact factor: 4.965

9.  Racial disparities in treatment preferences for rheumatoid arthritis.

Authors:  Florina Constantinescu; Suzanne Goucher; Arthur Weinstein; Liana Fraenkel
Journal:  Med Care       Date:  2009-03       Impact factor: 2.983

10.  Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy.

Authors:  Jennifer L Barton
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.